Acción A004310 HYUNDAI PHARMACEUTICAL CO., LTD.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Hyundai Pharmaceutical Co., Ltd.

Acciones

A004310

KR7004310009

Precio de cierre Korea S.E.
Otros sitios de cotización
 00:00:00 14/05/2024 		Varia. Cinco días. Varia. 1 de enero.
3.760 KRW -0,27 % Gráfico intradía de Hyundai Pharmaceutical Co., Ltd. -0,66 % -8,52 %
2023 Hyundai Pharmaceutical Co. (KOSE:A004310) anuncia una recompra de acciones por valor de 3.000 millones de KRW. CI
2023 Hyundai Pharmaceutical Co., Ltd. autoriza un plan de recompra. CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.
Hyundai Pharmaceutical Co., Ltd.(KOSE:A004310) dropped from S&P Global BMI Index
Hyundai Pharmaceutical Co., Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares.
Hyundai Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 23, 2022.
Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 23, 2022.
Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 23, 2022.
Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 23, 2022.
Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 23, 2022.
Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback announced on June 23, 2022, has expired with 968,118 shares, representing 3.50% for KRW 4,388.11 million.
Hyundai Pharmaceutical Co., Ltd. announces an Equity Buyback for KRW 5,000 million worth of its shares.
Hyundai Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
Market Chatter: Hyundai Pharmaceutical Seeks Regulatory Approval to Market Abortion Pill in South Korea
Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback announced on July 14, 2008, has expired.
Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback announced on April 22, 2010, has expired.
Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback announced on June 28, 2019, has expired.
Hyundai Pharmaceutical Co., Ltd.(KOSE:A004310) added to S&P Global BMI Index
Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan Extended till June 25, 2021.
Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan Extended till April 16, 2021.
Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 28, 2019.
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción A004310
  4. Noticias Hyundai Pharmaceutical Co., Ltd.
  5. Otros idiomas